Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020
Emerging autologous cellular therapies that utilize platelet-rich plasma (PRP) applications
have the potential to play adjunctive roles in a variety of regenerative medicine treatment …
have the potential to play adjunctive roles in a variety of regenerative medicine treatment …
Bone stress injuries
T Hoenig, KE Ackerman, BR Beck… - Nature Reviews …, 2022 - nature.com
Bone stress injuries, including stress fractures, are overuse injuries that lead to substantial
morbidity in active individuals. These injuries occur when excessive repetitive loads are …
morbidity in active individuals. These injuries occur when excessive repetitive loads are …
Intra-articular treatment options for knee osteoarthritis
Intra-articular drug delivery has a number of advantages over systemic administration;
however, for the past 20 years, intra-articular treatment options for the management of knee …
however, for the past 20 years, intra-articular treatment options for the management of knee …
Platelet-rich plasma: a narrative review
T Collins, D Alexander, B Barkatali - EFORT open reviews, 2021 - eor.bioscientifica.com
The aim of this article was to synopsize platelet-rich plasma (PRP) use in musculoskeletal
pathologies through evidence-based assessment of the preparation, classification …
pathologies through evidence-based assessment of the preparation, classification …
A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: The unsolved challenge
Despite its intrinsic ability to regenerate form and function after injury, bone tissue can be
challenged by a multitude of pathological conditions. While innovative approaches have …
challenged by a multitude of pathological conditions. While innovative approaches have …
Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system
Introduction Platelet-rich plasma (PRP) is able to modulate the joint environment by
reducing the inflammatory distress and promoting tissue anabolism. Therefore, it has gained …
reducing the inflammatory distress and promoting tissue anabolism. Therefore, it has gained …
Platelet rich plasma: new insights for cutaneous wound healing management
D Chicharro-Alcántara, M Rubio-Zaragoza… - Journal of functional …, 2018 - mdpi.com
The overall increase of chronic degenerative diseases associated with ageing makes
wound care a tremendous socioeconomic burden. Thus, there is a growing need to develop …
wound care a tremendous socioeconomic burden. Thus, there is a growing need to develop …
Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and …
M McLarnon, N Heron - BMC musculoskeletal disorders, 2021 - Springer
Background Intra-articular (IA) corticosteroid (CS) injections are the mainstay of treatment for
symptomatic management in knee osteoarthritis (OA), particularly in the UK. IA platelet-rich …
symptomatic management in knee osteoarthritis (OA), particularly in the UK. IA platelet-rich …
Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee
CS Cook, PA Smith - Current reviews in musculoskeletal medicine, 2018 - Springer
Abstract Purpose of Review The purpose of this review is to update the reader on the current
applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This …
applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This …
[HTML][HTML] Fracture non-union: a review of clinical challenges and future research needs
SK Stewart - Malaysian orthopaedic journal, 2019 - ncbi.nlm.nih.gov
Non-union of bone following fracture is an orthopaedic condition with a high morbidity and
clinical burden. Despite its estimated global prevalence of nine million annually, the limit of …
clinical burden. Despite its estimated global prevalence of nine million annually, the limit of …